Login
$ARDT
$12.18 -$0.09 (0.73%) Close

Company Executives

$ARDT Management Team

Mr. David Caspers

Chief Operating Officer

Age 54
Compensation -
Sex Male

Mr. Mark Sotir

Non-Executive Independent Chairman of the Board

Age 61
Compensation $350.0K USD
Sex Male

Mr. Marty Bonick

President

Chief Executive Officer

Director

Age 51
Compensation $6.939M USD
Sex Male

Mr. Alfred Lumsdaine

Chief Financial Officer

Age 59
Compensation $3.428M USD
Sex Male

Mr. Ethan Chernin

President - Health Services

Age 42
Compensation $1.493M USD
Sex Male

Mr. Stephen Petrovich

Executive Vice President

General Counsel

Assistant Secretary

Age 58
Compensation $2.038M USD
Sex Male

Mr. Dave Styblo

Senior Vice President

Investor Relations Contact

Age -
Compensation -
Sex Male
Directors
11
serving now
Independent
9 of 11
stated in the proxy
Average tenure
6.2 years
from year joined
CEO also chairs the board
No
Mark Sotir
Director Age On board Independent Committees Other public boards 2025 pay Source
Mark Sotir
62 2017
9 years
Independent None stated None stated $394,716
Martin J. Bonick
52 Not stated Not independent None stated None stated Paid as CEO
Peter Bulgarelli
66 2018
8 years
Not independent
Compensation Committee Patient Safety and Quality of Care Committee
None stated Not stated
Peter Bynoe
75 2015
11 years
Independent
Nominating and Corporate Governance Committee · Chair
None stated $294,716
Suzanne Campion
64 2021
5 years
Independent
Compensation Committee Nominating and Corporate Governance Committee
None stated $287,216
Robert A. DeMichiei
61 2025
1 year
Independent
Nominating and Corporate Governance Committee
Waystar Holding Corp. (Nasdaq: WAY), Ampco-Pittsburgh Corporation (NYSE: AP) $221,011
William Goodyear
77 2019
7 years
Independent
Audit and Compliance Committee · Chair
None stated $307,216
Ellen Havdala
60 2019
7 years
Independent None stated None stated $299,716
Edmondo Robinson
50 2022
4 years
Independent
Patient Safety and Quality of Care Committee · Chair
Carriage Services, Inc. (NYSE: CSV) $304,716
Rahul Sen
35 2020
6 years
Independent
Compensation Committee
None stated $287,216
Rob Webb
56 2022
4 years
Independent
Patient Safety and Quality of Care Committee
None stated $294,716

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

9 disclosed in the proxy filed Apr 8, 2026
Pure Health
purchased a 26.1% interest in the Company
Approximately $500 million
2023

Pure Health bought a 26.1% interest in the Company from unitholders

With the unitholders Open in proxy
Ventas
$26.0 million

Company repurchased Ventas's noncontrolling interest in AHP Health Partners, Inc. under tag-along rights

With the Company Open in proxy
Ventas
$204.0 million
2022

Sale of 18 medical office buildings to Ventas with leaseback of the real estate

With the Company Open in proxy
Ventas
Amount not stated

20-year master lease of ten hospitals from Ventas subsidiaries with covenants and guarantees

With subsidiaries of Ventas Open in proxy
Ventas
Amount not stated

Relative Rights Agreement governing relative rights, cross-acceleration and a purchase option on tenant debt

With the administrative agents under the Senior Secured Credit Facilities and the trustee of the 5.75% Senior Notes Open in proxy
EGI-AM, Ventas and certain executive officers and management team
investors party to the Registration Rights Agreement
Amount not stated

Registration Rights Agreement providing demand and piggyback registration rights

With the Company Open in proxy
EGI-AM
Amount not stated

Letter agreement under which EGI-AM provides strategic, advisory and consulting services without a fee; expenses reimbursable

With the Company Open in proxy
EGI-AM
nomination rights holder
Amount not stated

Nomination Agreement giving EGI-AM and ALH Holdings, LLC rights to nominate directors

With ALH Holdings, LLC Open in proxy
Ventas
stockholder
Amount not stated

REIT savings agreement giving Ventas repurchase and transfer rights to keep its ownership below 9.9%

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support